Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/1923
Estimating the number of SARS-CoV-2 infections in the United States
Dayton G Thorpe.
Kelsey Lyberger.
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1101/2020.04.13.20064519
We apply a model developed by The COVID-19 Response Team [S. Flaxman, S. Mishra, A. Gandy, et al., "Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries," tech. rep., Imperial College London, 2020.] to estimate the total number of SARS-CoV-2 infections in the United States. Across the United States we estimate as of 6 April 2020 the fraction of the population infected was 4.8% [3.2%, 8.0%], 39 times the portion of the population with a positive test result. Excluding New York state, which we estimate accounts for over half of infections in the United States, we estimate an infection rate of 2.0% [1.7%, 2.6%]. We include the timing of each state's implementation of interventions including encouraging social distancing, closing schools, banning public events, and a lockdown / stay-at-home order. We assume fatalities are reported correctly and infer the number and timing of infections based on the infection fatality rate measured in populations that were tested universally for SARS-CoV-2. Underreporting of deaths would drive our estimates to be too low. This model does not include effects of herd immunity; in states where the estimated infection rate is very high - namely, New York - our estimates may be too high.
www.medrxiv.org
2020
Artículo
https://www.medrxiv.org/content/10.1101/2020.04.13.20064519v2.full.pdf
Inglés
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos:


Fichero Tamaño Formato  
1100499.pdf10.73 MBAdobe PDFVisualizar/Abrir